Concepedia

Author

Bruce E. Miller

GlaxoSmithKline (United States)ORCID

Also Known As

B Celli, B E Miller, B Miller, B. E. Miller, B. MILLER, B. Miller, B.E Miller, B.E. Miller, BRUCE E. MILLER, Bruce Miller

280

Publications

17.6K

Citations

61

H-Index

154

Concepts

All Affiliations

GlaxoSmithKline (United States)Brigham and Women's HospitalUniversity of Nebraska Medical CenterManchester Academic Health Science CentreResearch Triangle Park Foundation
BE

About

Bruce E. Miller is an author at GlaxoSmithKline (United States) specializing in medicine, pulmonary disease, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

43

3.4K

2

Engineering

8

8

399

3

Natural Sciences

6

6

168

4

Education

1

1

86

5

Health Sciences

1

1

21

Bruce E. Miller

×

137

Publications

15K

Citations

56

H-Index

YearCitations

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

John R. Hurst, Jørgen Vestbo, Antonio Anzueto,

New England Journal of Medicine

2010

2.9K

Changes in Forced Expiratory Volume in 1 Second over Time in COPD

Jørgen Vestbo, Lisa Edwards, Paul D. Scanlon,

New England Journal of Medicine

2011

935

Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

Àlvar Agustí, Lisa Edwards, Stephen I. Rennard,

PLoS ONE

2012

833

Lung microbiome dynamics in COPD exacerbations

Zhang Wang, Mona Bafadhel, Koirobi Haldar,

European Respiratory Journal

2016

449

Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort

Joy Miller, Lisa Edwards, Àlvar Agustí,

Respiratory Medicine

2013

423

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

Bartolomé R. Celli, Nicholas Locantore, Julie Yates,

American Journal of Respiratory and Critical Care Medicine

2012

423

Six-Minute-Walk Test in Chronic Obstructive Pulmonary Disease

Michael I. Polkey, Martijn A. Spruit, Lisa Edwards,

American Journal of Respiratory and Critical Care Medicine

2012

319

Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis

Zhang Wang, Nicholas Locantore, Koirobi Haldar,

American Journal of Respiratory and Critical Care Medicine

2020

277

The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

Harvey O. Coxson, Asger Dirksen, Lisa Edwards,

The Lancet Respiratory Medicine

2013

268

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations

David Mayhew, Nathalie Devos, Christophe Lambert,

Thorax

2018

267

Page 1